Briefing: GOP Senator Investigates FDA Over Rare Disease Drug Rejections
Strategic angle: Sen. Ron Johnson raises concerns about the FDA's handling of treatments for rare diseases after discussions with Commissioner Marty Makary.
Editorial Staff
1 min read
Updated 4 months ago
Sen. Ron Johnson is questioning the FDA's drug approval process.
Focus on treatments for rare diseases that have been rejected.
Discussion with FDA Commissioner Marty Makary highlights concerns.